{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T21:56:06Z","timestamp":1775858166967,"version":"3.50.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1097\/mol.0b013e32835c8c1a","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T08:16:42Z","timestamp":1355386602000},"page":"153-159","source":"Crossref","is-referenced-by-count":36,"title":["Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol"],"prefix":"10.1097","volume":"24","author":[{"given":"Vineeta","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trudy M.","family":"Forte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert O.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20211004","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1064852","article-title":"An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.","volume":"294","author":"Pennacchio","year":"2001","journal-title":"Science"},{"key":"R2-10-20211004","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bbalip.2011.12.002","article-title":"Apolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlement.","volume":"1821","author":"Sharma","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"R3-10-20211004","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1093\/hmg\/11.24.3031","article-title":"Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.","volume":"11","author":"Pennacchio","year":"2002","journal-title":"Hum Mol Genet"},{"key":"R4-10-20211004","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1515\/CCLM.2007.056","article-title":"Polymorphisms in the APOA1C3A4A5 gene cluster and cholesterol responsiveness to dietary change.","volume":"45","author":"Hubacek","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"R5-10-20211004","first-page":"7","article-title":"Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans.","volume":"10","author":"Chandak","year":"2006","journal-title":"BMC Med Genet"},{"key":"R6-10-20211004","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1194\/jlr.M400192-JLR200","article-title":"Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study.","volume":"11","author":"Lai","year":"2004","journal-title":"J Lipid Res"},{"key":"R7-10-20211004","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2310\/JIM.0b013e3182686918","article-title":"Mutation screening of the APOA5 gene in subjects with coronary artery disease.","volume":"7","author":"Soufi","year":"2012","journal-title":"J Investig Med"},{"key":"R8-10-20211004","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1093\/hmg\/ddg255","article-title":"A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia.","volume":"12","author":"Kao","year":"2003","journal-title":"Hum Mol Genet"},{"key":"R9-10-20211004","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1194\/jlr.P800011-JLR200","article-title":"An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients.","volume":"49","author":"Pullinger","year":"2008","journal-title":"J Lipid Res"},{"key":"R10-10-20211004","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cca.2011.09.045","article-title":"Functional importance of apolipoprotein gene cluster on human chromosome 11.","volume":"1-","author":"Huang","year":"2012","journal-title":"Clin Chim Acta"},{"key":"R11-10-20211004","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ygeno.2003.11.016","article-title":"Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11.","volume":"83","author":"Olivier","year":"2004","journal-title":"Genomics"},{"key":"R12-10-20211004","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1161\/ATVBAHA.110.210815","article-title":"Intravenous injection of apolipoprotein A-V reconstituted High-density lipoprotein decreases hypertriglyceridemia in apoav-- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein.","volume":"30","author":"Shu","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R13-10-20211004","first-page":"1716","article-title":"Triglycerides and heart disease: still a hypothesis Arterioscler Thromb Vasc B","volume":"31","author":"Goldberg","year":"2011","journal-title":"iol"},{"key":"R14-10-20211004","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCRESAHA.108.179861","article-title":"Atheroprotective effect of human apolipoprotein A5 in a mouse model of mixed dyslipidemia.","volume":"103","author":"Mansouri","year":"2008","journal-title":"Circ Res"},{"key":"R15-10-20211004","doi-asserted-by":"crossref","first-page":"25383","DOI":"10.1074\/jbc.M501589200","article-title":"Apolipoprotein A-V heparin interactions. Implications for plasma lipoprotein metabolism.","volume":"280","author":"Lookene","year":"2005","journal-title":"J Biol Chem"},{"key":"R16-10-20211004","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2012.04.011","article-title":"Apolipoprotein A-V modulates multiple atherogenic mechanisms in a mouse model of disturbed clearance of triglyceride-rich lipoproteins.","volume":"224","author":"Grosskopf","year":"2012","journal-title":"Atherosclerosis"},{"key":"R17-10-20211004","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1194\/jlr.R800050-JLR200","article-title":"The ins (Cell) and outs (Plasma) of plasma apolipoprotein A-V.","volume":"50","author":"Forte","year":"2009","journal-title":"J Lipid Res"},{"key":"R18-10-20211004","doi-asserted-by":"crossref","first-page":"34438","DOI":"10.1074\/jbc.M303784200","article-title":"Structure and interfacial properties of human aolipoprotein A-V.","volume":"278","author":"Weinberg","year":"2003","journal-title":"J Biol Chem"},{"key":"R19-10-20211004","doi-asserted-by":"crossref","first-page":"15484","DOI":"10.1074\/jbc.M611797200","article-title":"The C terminus of apolipoprotein A-V modulates lipid-binding activity.","volume":"282","author":"Beckstead","year":"2007","journal-title":"J Biol Chem"},{"key":"R20-10-20211004","doi-asserted-by":"crossref","first-page":"8768","DOI":"10.1021\/bi800515c","article-title":"The N-terminus of apolipoprotein A-V adopts a helix bundle molecular architecture.","volume":"47","author":"Wong","year":"2008","journal-title":"Biochemistry"},{"key":"R21-10-20211004","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1172\/JCI24471","article-title":"Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.","volume":"115","author":"Marcais","year":"2005","journal-title":"J Clin Invest"},{"key":"R22-10-20211004","doi-asserted-by":"crossref","first-page":"33369","DOI":"10.1074\/jbc.M109.040972","article-title":"Apolipoprotein A-V N-terminal domain altered lipid interaction properties in vitro explain hypertriglyceridemic phenotype associated with natural truncation mutants.","volume":"284","author":"Wong-Mauldin","year":"2009","journal-title":"J Biol Chem"},{"key":"R23-10-20211004","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1021\/bi1005859","article-title":"The carboxyl terminal segment of apolipoprotein A-V undergoes a lipid-induced conformational change.","volume":"49","author":"Mauldin","year":"2010","journal-title":"Biochemistry"},{"key":"R24-10-20211004","doi-asserted-by":"crossref","first-page":"44512","DOI":"10.1074\/jbc.M106888200","article-title":"Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration.","volume":"276","author":"van der Vliet","year":"2001","journal-title":"J Biol Chem"},{"key":"R25-10-20211004","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1042\/bj2770723","article-title":"Biosynthesis and secretion of triacylglycerol in rat liver after partial hepatectomy.","volume":"277","author":"Tijburg","year":"1991","journal-title":"Biochem J"},{"key":"R26-10-20211004","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1194\/jlr.C700002-JLR200","article-title":"ApoA-V association with intracellular lipid droplets.","volume":"48","author":"Shu","year":"2007","journal-title":"J Lipid Res"},{"key":"R27-10-20211004","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1194\/jlr.M800111-JLR200","article-title":"Intracellular lipid droplet targeting by apolipoprotein A-V requires the carboxyl-terminal segment.","volume":"49","author":"Shu","year":"2008","journal-title":"J Lipid Res"},{"key":"R28-10-20211004","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1146\/annurev-biochem-061009-102430","article-title":"Lipid droplets and cellular lipid metabolism.","volume":"81","author":"Walther","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"R29-10-20211004","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbalip.2010.02.004","article-title":"Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation.","volume":"1801","author":"Shu","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"R30-10-20211004","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/gut.2010.222224","article-title":"The role of apolipoprotein A5 in nonalcoholic fatty liver disease.","volume":"60","author":"Ress","year":"2011","journal-title":"Gut"},{"key":"R31-10-20211004","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1194\/jlr.M010793","article-title":"Biogenesis of apolipoprotein A-V and its impact on VLDL triglyceride secretion.","volume":"52","author":"Blade","year":"2011","journal-title":"J Lipid Res"},{"key":"R32-10-20211004","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbrc.2012.09.065","article-title":"Influence of apolipoprotein A-V on hepatocyte lipid droplet formation.","volume":"427","author":"Gao","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"R33-10-20211004","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1074\/jbc.M211932200","article-title":"Expressing cloning and characterization of a novel glycosylphosphatidylinositol-anchored high density lipoprotein binding protein, GPIHBP1.","volume":"278","author":"Ioka","year":"2003","journal-title":"J Biol Chem"},{"key":"R34-10-20211004","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cmet.2007.02.002","article-title":"Glycosylphosphatidyl-inositol-anchored high density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons.","volume":"5","author":"Beigneux","year":"2007","journal-title":"Cell Metab"},{"key":"R35-10-20211004","doi-asserted-by":"crossref","first-page":"29554","DOI":"10.1074\/jbc.M802579200","article-title":"The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons.","volume":"283","author":"Gin","year":"2008","journal-title":"J Biol Chem"},{"key":"R36-10-20211004","doi-asserted-by":"crossref","first-page":"19735","DOI":"10.1074\/jbc.M111.242024","article-title":"Assessing the role of the glycosylphospatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1) three-finger domain in binding lipoprotein lipase.","volume":"286","author":"Beigneux","year":"2011","journal-title":"J Biol Chem"},{"key":"R37-10-20211004","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/ATVBAHA.109.186577","article-title":"Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase.","volume":"29","author":"Beigneux","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R38-10-20211004","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/CIRCGENETICS.109.908905","article-title":"Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects.","volume":"3","author":"Franssen","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"R39-10-20211004","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1194\/jlr.M002717","article-title":"Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia.","volume":"51","author":"Olivecrona","year":"2010","journal-title":"J Lipid Res"},{"key":"R40-10-20211004","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10545-011-9406-5","article-title":"Deletion of GPIHBP1 causing severe chylomicronemia.","volume":"35","author":"Rios","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"R42-10-20211004","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1194\/jlr.R800030-JLR200","article-title":"GPIHBP1, a GPI anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins.","volume":"50","author":"Beigneux","year":"2009","journal-title":"J Lipid Res"},{"key":"R43-10-20211004","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/ATVBAHA.110.214718","article-title":"Binding Preferences for Glycosylphosphatidylinositol HBP1, a Glycosylphosphatidylinositol-Anchored Protein of Capillary Endothelial Cells.","volume":"31","author":"Gin","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R44-10-20211004","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MOL.0b013e3281527914","article-title":"GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons.","volume":"18","author":"Young","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"R45-10-20211004","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1373\/clinchem.2004.040824","article-title":"The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins.","volume":"51","author":"OBrien","year":"2005","journal-title":"Clin Chem"},{"key":"R46-10-20211004","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1194\/jlr.M700281-JLR200","article-title":"Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice.","volume":"49","author":"Nelbach","year":"2008","journal-title":"Lipid Res"},{"key":"R47-10-20211004","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.atherosclerosis.2006.05.030","article-title":"Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.","volume":"193","author":"Henneman","year":"2007","journal-title":"Atherosclerosis"},{"key":"R48-10-20211004","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s00125-006-0387-0","article-title":"The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II.","volume":"49","author":"Talmud","year":"2006","journal-title":"Diabetologia"},{"key":"R49-10-20211004","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1194\/jlr.M600233-JLR200","article-title":"Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study.","volume":"47","author":"Vaessen","year":"2006","journal-title":"J Lipid Res"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00041433-201304000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T02:31:09Z","timestamp":1633314669000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041433-201304000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0b013e32835c8c1a","relation":{},"ISSN":["0957-9672"],"issn-type":[{"value":"0957-9672","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}